More evidence for the involvement of IL-1β in MS pathogenesis comes from studies demonstrating that elevated IL-1β levels in cerebrospinal fluid (CSF) and blood of MS patients correlate with disease susceptibility, severity, and progression [38–43]. Here, IL1B is linked to myeloid sarcoma.